abstract |
The present invention relates to oligonucleotides capable of inhibiting the expression of the protein IRS-1 and of inhibiting the formation of capillary tubes by endothelial cells. The oligonucleotides according to the invention are indicated as an anti-angiogenic agent. They are also indicated as anti-cell multiplication agents, in particular as anti-tumor agents. |